Building on the success of the consortium’s first round, we announced a call for proposals and invited researchers in Qatar to leverage QPHI’s extensive genomic and health data for innovative studies that bridge basic research and practical applications. This research consortium is dedicated to advancing both basic and translational research, with a strong emphasis on implementing findings that directly benefit clinical and public health outcomes.
Please visit the following link for the list of QPHRC approved projects. link. 
 

In 2016/2017, Qatar Genome assembled the QGP Research Consortium (QGP-RC), which was divided into 10 main studies working on fundamental genetic analyses that were never addressed at this scale in an Arab population using whole genome data. The consortium included over 150 members of local researchers and their international collaborators.
The QGP-RC published several key publications in high impact journals providing foundational results that would fill a much-awaited literature gap on the genomics of Qatari and Arab populations. 
Please click the link to view the list of publications from the first round of the consortium

n a collaboration between Qatar National Research Fund (QNRF) and Qatar Genome, an annual grant scheme under the name Pathway Towards Precision Medicine (PPM) was launched in 2015 to support local researchers working on genomics and precision medicine. 
The large number of high-quality proposals submitted each year is clear evidence of the success of this initiative. The PPM continues to be the flagship grant by which QGP and QNRF support and direct genomic research in Qatar. The PPM grants aim to capitalize on the wealth of genomic and phenotypic data produced by QGP and QBB and help understand disease phenotype/genotype correlations and translate research findings into clinical outcomes for better future healthcare in Qatar. Seventh Cycle of Path Towards Precision Medicine (PPM)

The 7th cycle of PPM is now accepting submissions until the 30th of April 2024.

For more information please check the link: QRDI Portal - Opportunity View

The Q-BIG was established by QPHI in response to the exponential growth in the amount of data being produced locally in Qatar and to make the best use of the available bioinformatics resources. The group is a platform for all researchers to meet and share ideas and forge multicenter partnerships. 

This group is open for all! If you are interested in participating in the group events, please contact csaad@qf.org.qa

Founded in 2013, the Global Alliance for Genomics and Health (GA4GH) brings together a global community to advance human health through the responsible use of genomic data. By developing technical standards and policy frameworks, GA4GH supports the secure and voluntary use of genomic and health-related data worldwide. 
For more information, please visit the following link

TThe Global Biobank Meta-analysis Initiative (GBMI) provides a platform to facilitate collaboration among biobanks globally. By pooling resources and data, GBMI enhances genome-wide association studies, improves polygenic risk scores, and explores understudied diseases and traits. 
For more information, please visit the following link

The INTERVENE Consortium is dedicated to utilizing large-scale data resources to advance precision medicine. By focusing on AI-driven genetic risk scores, INTERVENE aims to improve the understanding of complex diseases and support tailored treatment strategies. 
For more information, please visit the following link

The Biobank Rare Variant Analysis (BRaVa) Consortium, established in 2022, unites global biobanks to study rare genetic variations. By harmonizing data and methodologies, BRaVa enhances research into rare diseases and traits that are challenging to investigate individually. For more information, please visit the following link

The COVID-19 Host Genetics Initiative unites researchers worldwide to identify genetic factors influencing COVID-19 susceptibility and outcomes. This knowledge aims to support drug development, risk identification, and a deeper understanding of SARS-CoV-2 biology. For more information, please visit the following link

The GenCOST Consortium focuses on understanding the genetic factors influencing healthcare costs worldwide. By analyzing genetic data alongside healthcare utilization and cost information, GenCOST aims to identify genetic pathways that impact overall health and evaluate the cost-effectiveness of genetic-based screening tools, such as polygenic scores. For more information, please visit the following link

The GenCOST Consortium focuses on understanding the genetic factors influencing healthcare costs worldwide. By analyzing genetic data alongside healthcare utilization and cost information, GenCOST aims to identify genetic pathways that impact overall health and evaluate the cost-effectiveness of genetic-based screening tools, such as polygenic scores. For more information, please visit the following link

For more information, please visit the following link

For more information, please visit the following link